GE Healthcare has secured a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, to develop and gain regulatory approval for next-generation ultrasound technology with artificial intelligence (AI) applications.
The technology's primary objective is to assist clinicians of all skill levels in efficiently diagnosing and treating patients with lung pathologies and traumatic injuries to the abdomen, chest, and head.
Trauma is a significant cause of death in the United States, and quick, accurate care is essential for patient survival. This technology aims to expedite the detection, evaluation, and decision-making process for trauma patients, potentially improving their chances of survival.
GE Healthcare will expand its point-of-care ultrasound technology portfolio through this collaboration with BARDA to develop an advanced probe and ultrasound system with AI technology.
These devices will be designed to cover various injury types, including blunt and penetrating trauma, head trauma, lung injuries, and lung pathologies found in infectious diseases.
Click here to read the original news story.